Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Ambiq Micro, Inc.NYSE: AMBQ
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin grows in line with its trailing trend
Q1 FY2026 selling, general & admin of $9.73M rose 15.2% year over year, ahead of the +14.1% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 10.4% from the prior quarter.
Context
- Selling, general & admin amounted to 45.7% of revenue in FY2025, up 9.3 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 5 analysts of $48.41M (+46.0%) for the fiscal year ending Dec 2026, a step up from the +19.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $9.73M+10.4% QoQ
- Last fiscal yearDec 2025
- $33.15M+19.5% YoY
- LTMMar 2026
- $34.44M+14.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +15.2% | +52.9% | +37.7 pp |
| 1 year | +19.5% | +46.0% | +26.5 pp |
| 3-year CAGR | — | +38.2% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 33.15M USD
- Year-over-year change
- +19.5%
- 5-year CAGR
- +18.8%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 33.15M | +19.5% |
| FY2024 | 2024-12-31 | 27.74M | +3.7% |
| FY2023 | 2023-12-31 | 26.74M | — |
| FY2021 | 2021-12-31 | 19.13M | +36.6% |
| FY2020 | 2020-12-31 | 14M | — |
Selling, General & Admin vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +14.1% is the 7th highest of 11, against a peer median of +22.6%.
- Selling, general & admin amounts to 42.1% of revenue for AMBQ, versus a peer median of 62.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $198.06M USD | -2.3% | -4.3% | 62.3% | |
| LTM Mar 2026 | $196.2M USD | -9.2% | +10.4% | 27.5% | |
| LTM Mar 2026 | $162.92M USD | +13.4% | +13.7% | 65.5% | |
| LTM Mar 2026 | $93.8M USD | +40.6% | -1.5% | 31.0% | |
| LTM Mar 2026 | $67.58M USD | -7.8% | +4.0% | 45.1% | |
| LTM Mar 2026 | $50.01M USD | +26.8% | +11.6% | 65.0% | |
| LTM Mar 2026 | $42.42M USD | +77.4% | — | 105.1% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $34.44M USD | +14.1% | — | 42.1% |
| LTM Sep 2026 | $28.83M USD | +18.4% | -2.0% | 16.9% | |
| LTM Mar 2026 | $22.94M USD | +92.7% | +18.1% | 1625.6% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥21.46M CNY | +128.2% | -71.8% | — |
| Peer median (excluding AMBQ) | — | +22.6% | +4.0% | 62.3% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.97M | 91.01M | 65.54M | 76.07M | 72.51M |
| Cost of Revenue | 29.4M | 60.24M | 46.1M | 51.78M | 46.82M |
| Gross Profit | 21.57M | 30.77M | 19.44M | 24.29M | 25.7M |
| Gross Margin | 42.3% | 33.8% | 29.7% | 31.9% | 35.4% |
| Research & Development | 27.79M | 36.11M | 44.02M | 37.17M | 33.69M |
| Selling, General & Admin | 14M | 19.13M | 26.74M | 27.74M | 33.15M |
| Operating Expenses | 41.79M | 55.87M | 70.76M | 64.9M | 66.84M |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| EBITDA | (18.29M) | (21.85M) | (42.59M) | (33.39M) | (29.21M) |
| EBITDA Margin | -35.9% | -24.0% | -65.0% | -43.9% | -40.3% |
| Operating Income | (20.22M) | (25.1M) | (51.32M) | (40.61M) | (41.14M) |
| Operating Margin | -39.7% | -27.6% | -78.3% | -53.4% | -56.7% |
| Interest Income | 0 | 43K | 0 | 0 | 0 |
| Interest Expense | 4.58M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (4.98M) | (216K) | 1.02M | 980K | 4.72M |
| Income Before Tax | (25.2M) | (25.32M) | (50.3M) | (39.63M) | (36.42M) |
| Pre-Tax Margin | -49.4% | -27.8% | -76.8% | -52.1% | -50.2% |
| Income Tax Expense | 25K | 25K | 30K | 28K | 40K |
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Net Margin | -49.5% | -27.8% | -76.8% | -52.1% | -50.3% |
| EPS (Basic) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| EPS (Diluted) | (1.85) | (0.10) | (5.00) | (3.13) | (4.57) |
| Weighted Avg Shares | 13.61M | 248.89M | 10.45M | 13.54M | 7.98M |
| Weighted Avg Shares (Diluted) | 13.61M | 248.89M | 10.45M | 13.61M | 7.98M |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.